Xin Li

13.5k total citations · 1 hit paper
390 papers, 9.6k citations indexed

About

Xin Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xin Li has authored 390 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Molecular Biology, 125 papers in Cancer Research and 96 papers in Oncology. Recurrent topics in Xin Li's work include Cancer-related molecular mechanisms research (63 papers), RNA modifications and cancer (51 papers) and MicroRNA in disease regulation (44 papers). Xin Li is often cited by papers focused on Cancer-related molecular mechanisms research (63 papers), RNA modifications and cancer (51 papers) and MicroRNA in disease regulation (44 papers). Xin Li collaborates with scholars based in China, United States and Hong Kong. Xin Li's co-authors include Hua Tang, Min Liu, Haiying Wan, Tao Liu, Weiyi Fang, Min Liu, Xiaoming Lyu, Kai‐Tai Yao, Min Liu and Huiling Yang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xin Li

374 papers receiving 9.5k citations

Hit Papers

Boosting anti-PD-1 therapy with metformin-loaded macropha... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Xin Li
Comparison fields: 5 of 166
  • Molecular Biology 5.5k
  • Cancer Research 3.4k
  • Oncology 1.9k
  • Immunology 1.2k
  • Pulmonary and Respiratory Medicine 1.0k
Replace Li Fu with:
Li Fu China
Xiayu Li China
Dan Li China
Shih‐Hwa Chiou Taiwan
Rui Manuel Reis Brazil
Ajay P. Singh United States
Yong Peng China
Lorraine O’Driscoll Ireland
Chen Liang China
Bingya Liu China
Li Fu China View profile →
Citations per field, relative to Xin Li
Xin Li · 1×
Citations per year, relative to Xin Li
Xin Li · 1×

Countries citing papers authored by Xin Li

Since Specialization
Citations

This map shows the geographic impact of Xin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Li more than expected).

Fields of papers citing papers by Xin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Li. The network helps show where Xin Li may publish in the future.

Co-authorship network of co-authors of Xin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Li. A scholar is included among the top collaborators of Xin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Li. Xin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 3
4 7
5 3
6 0
7 0
8 2
9 2
10 12
11 6
12 7
13 10
14 3
15 16
16 7
17 8
18 117
19 88
20 122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026